Trial intelligence / Profile preview

FAPI-PET Imaging to Evaluate TAVI Effects in Aortic Stenosis

NCT07335900Recruiting

Sponsor
Renji Hospital
Start
Dec 2025
Primary completion
Dec 2026
Countries
1
01

Overview

Open-label trial (2 arms), sponsored by Renji Hospital. Primary endpoint: FAPI-PET myocardial uptake value at 6 months. Started Dec 2025; status: recruiting.

Beyond the preview

Go deeper on NCT07335900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07335900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call